Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meeting.26-02-2018
26-02-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Reg 30 (LODR) - Analyst/ Investor Meet- Intimation21-02-2018
Announcement under Regulation 30 (LODR)-Updates
Intimation regarding a request received from a member of the Promoter Group for reclassification from the Promoter/Promoter Group of HealthCare Global Enterprises Limited.19-02-2018
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; we wish to inform you that the Company has executed a Limited Liability Partnership Agreement ('The Agreement') with Shiv-Sun with respect to the relationship between the HCG and Shiv-Sun ('Partners' or 'Parties'), their rights, obligations as Partners in HCG SUN HOSPITALS LLP ('the LLP') and other matters in connection therewith.16-02-2018
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
We wish to inform you that, pursuant to Section 233 of the Companies Act 2013, and other applicable provisions, the Regional Director, Ministry of Corporate Affairs, Hyderabad, has approved the Scheme of Amalgamation of HCG Pinnacle with the Company on January 30, 2018 ('the Scheme'). We are in receipt of the original order along with the Scheme, and are enclosing a copy of the same for your information and records.16-02-2018
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
We wish to inform you that, pursuant to Section 233 of the Companies Act 2013, and other applicable provisions, the Regional Director, Ministry of Corporate Affairs, Hyderabad, has approved the Scheme of Amalgamation of DKR with BACC on January 29, 2018 ('the Scheme'). BACC is a subsidiary of the Company, and DKR is a wholly owned subsidiary of BACC. We are in receipt of the original order along with the Scheme, and are enclosing a copy of the same for your information and records.16-02-2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Franklin Templeton Mutual Fund16-02-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for investment of Quadria Capital in Strand Life Sciences Private Limited.12-02-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meeting.12-02-2018
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
In continuation of the intimation made to the stock exchanges on January 03, 2018, on the execution of Business Transfer Agreement, Share Subscription Agreement and Shareholders 'Agreement by the Company with Strand Life Sciences, we wish to inform you that, the transaction under the Business Transfer Agreement and the Share Subscription Agreement has been completed....09-02-2018